The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19

• Conditions: Covid19; Diabetes Mellitus
• Interventions: Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

• Registration Number: NCT04591704
• Lead Sponsor: Uşak University

Brief Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Detailed Description

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.

The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Study Timeline

• Study Start: 2020-03-20
• Primary Completion: 2020-10-15
• Study First Submitted: 2020-10-16
• Study First Submitted QC: 2020-10-16
• Study First Posted: 2020-10-19
• Status Verified: 2021-05
• Last Update Submitted: 2021-05-01
• Last Update Posted: 2021-05-04
• Study Completion: 2021-07-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Patients hospitalized for COVID-19

Exclusion Criteria

• Patients with known malignancy
• Pregnant patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Diabetic groups	hospitalisation, necessity of ICU, mortality rate, lung involvement	COVID-19 patients with diabetes mellitus
Control groups	hospitalisation, necessity of ICU, mortality rate, lung involvement	COVID-19 patients without diabetes mellitus

Primary Outcome Measures

Name	Time	Method
Duration of Hospitalisation	1 year	The time between admission to hospital and discharge
The need for ICU	1 year	The admission of hospitalized patients to the intensive care unit.
Mortality	1 year	Mortality rates of patients
Lung involvement	1 year	The presence of lung involvement on thorax CT

Trial Locations

Locations (1)

Usak University Training and Research Hospital; 🇹🇷 Usak, Turkey